Sponsor or institution

Clinical trials and research at New Mexico Cancer Research Alliance

As of November 12, 2026, Find a Trial lists 4 clinical trials run by New Mexico Cancer Research Alliance that are recruiting, in United States. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Progestins before surgery for endometrial cancer or precancers Phase 2 Iowa City, Iowa and 3 other locations Recruiting Feb 27, 2026
Engaging American Indians in cancer genome sequencing — Albuquerque, New Mexico Recruiting Jan 17, 2024
A program to collect cancer-related samples and data for better cancer care — Albuquerque, New Mexico Recruiting Jun 6, 2019
Collecting fluid from ovarian cancer patients to test new therapies — Albuquerque, New Mexico Recruiting May 9, 2019

All recruiting trials (4)

Quick answers

How many clinical trials run by New Mexico Cancer Research Alliance are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.